Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity
about
Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesisAnti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipidsDimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'Identification of an atypical lipoprotein-binding protein from human aortic smooth muscle as T-cadherinDomain V of beta2-glycoprotein I binds factor XI/XIa and is cleaved at Lys317-Thr318Role of beta 2-glycoprotein I in the antiphospholipid antibody binding to endothelial cells.beta 2-Glycoprotein I: target antigen for autoantibodies in the 'antiphospholipid syndrome'.Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI.Accelerated atheroma and anti-beta2-glycoprotein I antibodies.Association of anticardiolipin antibodies with vascular injury: possible mechanisms.β2-Glycoprotein I-specific T cells are associated with epitope spread to lupus-related autoantibodies.Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I.Interactions between Hepatitis C Virus and the Human Apolipoprotein H Acute Phase Protein: A Tool for a Sensitive Detection of the VirusThe Fifth Domain of Beta 2 Glycoprotein I Protects from Natural IgM Mediated Cardiac Ischaemia Reperfusion Injuryβ2-Glycoprotein I Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Phosphorylation of Extracellular Signal-Regulated Kinase 1/2, Akt, and Endothelial Nitric Oxide Synthase.The interaction of beta(2)-glycoprotein I domain V with chaperonin GroEL: the similarity with the domain V and membrane interactionAntiphospholipid antibodies: laboratory and pathogenetic aspects.Anticardiolipin antibodies in proliferative diabetic retinopathy: An additional risk factor.Beta 2-Glycoprotein I binds factor XI and inhibits its activation by thrombin and factor XIIa: loss of inhibition by clipped beta 2-glycoprotein I.Optimization of unnicked β2-glycoprotein I and high avidity anti-β2-glycoprotein I antibodies isolation.Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I.Molecular studies on phospholipid-binding sites and cryptic epitopes appearing on beta 2-glycoprotein I structure recognized by anticardiolipin antibodies.Beta 2-glycoprotein I.The role of beta 2-glycoprotein I in the antiphospholipid syndrome.Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface.Binding of plasma proteins to titanium dioxide nanotubes with different diameters.Microheterogeneity of beta-2 glycoprotein I: implications for binding to anionic phospholipids.Epitope mapping studies of antiphospholipid antibodies and beta 2-GPI using synthetic peptides.Phospholipid-binding proteins differ in their capacity to induce autoantibodies and murine systemic lupus erythematosus.Concomitant isolation of protein C inhibitor and unnicked beta2-glycoprotein I.Diagnosis and management of the antiphospholipid syndrome.Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer.The binding site in {beta}2-glycoprotein I for ApoER2' on platelets is located in domain V.Antiphospholipid antibodies, beta 2-glycoprotein I and thrombosis.Plasma Protein β-2-Glycoprotein 1 Mediates Interaction between the Anti-tumor Monoclonal Antibody 3G4 and Anionic Phospholipids on Endothelial Cells
P2860
Q24293734-DE9BFD8E-E80D-474E-9173-3F29492371A2Q24561680-EB943D5A-A98B-4A5D-AFCD-33F7B4E963CCQ28179249-F646E6F8-AB46-4672-8D85-7667AE7C9529Q28262200-DCC01A21-9AF1-4EEF-B65C-3AB9ECE95EE6Q28291393-6A7E5D49-8EB4-4901-96CC-15D486D90ED2Q33489012-C05692E6-EE61-45C4-80A1-21FB253556CDQ33497587-B3AF8983-C7EA-4D87-9EC8-209303308224Q33504706-F56048B1-4E7B-4852-A40E-00AFF14F4399Q33915467-F52D216F-3CA4-4D8D-9A16-ACED3749564EQ34048278-8AA89185-23B6-4B0B-A5FD-DF13766B37D5Q35126642-8E4AE451-A993-4E4A-ADEB-EA540B73C9F5Q35419865-C4668E4C-EA2F-4555-A8D7-41669AEF4DD2Q35821487-23A421ED-77C0-42CF-9D2B-A2483C2E83B0Q35974974-A476D44B-9322-442B-A2CE-03653FA423FAQ36118474-7F7423F5-0193-4A92-BC73-1BBC771B5761Q36639649-AA654694-AD27-431B-90D0-785F6658E9D3Q36799474-B9BC0B07-E674-4498-8F87-2754145B6207Q37059992-59AAFBF7-E724-4D06-BA59-0027F5C8C97FQ37095385-EA180E89-5B95-4101-8280-AF848B498B19Q37704570-3E2FBE6D-51BF-4ECC-9D22-92BF86953DB1Q37721597-68E412F1-AC05-43BB-B974-77BE018D43A5Q37903952-93AAC357-3BDA-40E5-8892-62A436D22F13Q40400869-A15304D3-246B-4382-9B3B-6AF4DCFC04BCQ40558449-671988C1-1FAE-492F-ADBE-A59B1012FB3AQ41066141-7213C9ED-402A-4AB3-926C-6551E36C6BC9Q42084495-CC99CED4-5E64-4370-B876-6707ECD71C5AQ42151289-74009D3C-B0B9-446C-B3EE-83AC837D778AQ42993559-C724738F-E520-457E-B222-E9BC3D7569AFQ44892012-F38992BE-42B8-4C45-B73B-AD3B9B5F90E0Q46586191-BBA2211F-830D-4809-BEB8-38F0DA81E81DQ47829847-93B3372A-D070-4E60-B394-34E9F930A06FQ47982275-7632D63C-08CC-4221-ADA6-4B980301AE74Q49295345-9AEE8CAF-4ABE-4798-A4BA-36DFE39246E1Q51814798-9802538D-C074-4D2B-830E-2E8665DE2876Q53979828-92F53DE1-A35B-456F-B428-B5E4F9AA2AAEQ57372547-50E3158A-538B-43F6-96E5-4B43AAD09B97
P2860
Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Identification of a region of ...... pin antibody cofactor activity
@ast
Identification of a region of ...... pin antibody cofactor activity
@en
type
label
Identification of a region of ...... pin antibody cofactor activity
@ast
Identification of a region of ...... pin antibody cofactor activity
@en
prefLabel
Identification of a region of ...... pin antibody cofactor activity
@ast
Identification of a region of ...... pin antibody cofactor activity
@en
P2093
P2860
P356
P1476
Identification of a region of ...... pin antibody cofactor activity
@en
P2093
P2860
P304
P356
10.1073/PNAS.90.6.2141
P407
P577
1993-03-01T00:00:00Z